Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion

Cardiovascular Therapeutics

Volumn 32, Issue 2, 2014, Pages 52-56

  Enriquez, Andres ^a   Conde, Diego ^b   Hopman, Wilma ^a   Mondragon, Ignacio ^b   Chiale, Pablo A ^c   de Luna, Antoni Bayés ^d   Baranchuk, Adrian ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d Institut Català de Ciències Cardiovasculars   (Spain)

Author keywords

Atrial fibrillation; Interatrial block; Pharmacological cardioversion

Indexed keywords

ANTIARRHYTHMIC AGENT; PROPAFENONE; VERNAKALANT;

ADULT; ADVANCED INTERATRIAL BLOCK; ARTICLE; CARDIOVERSION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; P WAVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RISK; RISK FACTOR; SINGLE DRUG DOSE; SINUS RHYTHM; STATISTICAL ANALYSIS;

ATRIAL FIBRILLATION; INTERATRIAL BLOCK; PHARMACOLOGICAL CARDIOVERSION;

AGED; ANISOLES; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; HEART BLOCK; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPAFENONE; PYRROLIDINES; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896073869     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12063     Document Type: Article

References (31)

1. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-521.
2. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007;28:2803-2817.
3. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study. Am J Med 2002;113:359-364.
4. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
5. Schilling RJ. Cardioversion of atrial fibrillation: The use of antiarrhythmic drugs. Heart 2010;96:333-338.
6. Raitt MH, Volgman AS, Zoble RG, Charbonneau L, Padder FA, O'Hara GE, Kerr D. AFFIRM Investigators. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2006;151:390-396.
7. Duytschaever M, Haerynck F, Tavernier R, Jordaens L. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation. Pacing Clin Electrophysiol 1998;21(1 Pt 2):284-287.
8. Dahlin J, Svendsen P, Gadsbøll N. Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: A 5-year follow-up of 268 consecutive patients. Scand Cardiovasc J 2003;37:324-328.
9. Agarwal YK, Aronow WS, Levy JA, Spodick DH. Association of interatrial block with development of atrial fibrillation. Am J Cardiol 2003;91:882.
10. Budeus M, Hennersdorf M, Perings C, Wieneke H, Erbel R, Sack S. Prediction of the recurrence of atrial fibrillation after successful cardioversion with P wave signal averaged ECG. Ann Noninv Electrocardiol 2005;10:414-419.
11. Caldwell J, Koppikar S, Barake W, et al. Prolonged P-wave duration is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation. J Interv Card Electrophysiol 2013, (Epub ahead of print).
12. Koide Y, Yotsukura M, Ando H, Aoki S, Suzuki T, Sakata K, et al. Usefulness of P-wave dispersion in standard twelve lead electrocardiography to predict transition from paroxysmal to persistent atrial fibrillation. Am J Cardiol 2008;102:573-577.
13. Dixen U, Vang Larsen M, Ravn L, Parner J, Jensen GB. Signal-averaged P wave duration and the long-term risk of permanent atrial fibrillation. Scan Cardiovasc J 2008;42:31-37.
14. Bayés de Luna A, Platonov P, Cosio FG, et al. Interatrial blocks A separate entity from left atrial enlargement: A consensus report. J Electrocardiol 2012;45:445-51.
15. Conde D, Baranchuk A. Interatrial block as anatomical-electrical substrate for supraventricular arrhythmias: Bayes' syndrome. Arch Mex Cardiol 2013, (in press).
16. Daubert JC, Pavin D, Jauvert G, Mabo P. Intra- and interatrial conduction delay: Implications for cardiac pacing. Pacing Clin Electrophysiol 2004;27:507-525.
17. Takahisa Y, Masatake F, Tsuyoshi S, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: A prospective study. J Am Coll Cardiol 2000;35:405-413.
18. Gonna H, Gallagher MM, Guo XH, Yap YG, Hnatkova K, Camm AJ. P-Wave abnormality predicts recurrence of atrial fibrillation after electrical cardioversion: A prospective study. Ann Noninvasive Electrocardiol 2013, [Epub ahead of print].
19. Puech P. L'activite' electrique auriculaire normale et pathologuique. Paris: Masson, 1956;206.
20. Cosío FG, Martín-Peñato A, Pastor A, Núñez A, Montero MA, Cantale CP, Schames S. Atrial activation mapping in sinus rhythm in the clinical electrophysiology laboratory: Observations during Bachmann's bundle block. J Cardiovasc Electrophysiol 2004;15:524-531.
21. Hinojar R, Pastor A, Cosio FG. Bachmann block pattern resulting from inexcitable areas peripheral to the Bachmann's bundle: Controversial name or concept? Europace 2013;15:1272.
22. Waldo AL, Bush HL Jr, Gelband H, Zorn GL Jr, Vitikainen KJ, Hoffman BF. Effects on the canine P wave of discrete lesions in the specialized atrial tracts. Circ Res 1971;29:452-467.
23. Goyal SB, Spodick DH. Electromechanical dysfunction of the left atrium associated with interatrial block. Am Heart J 2001;142:823-827.
24. Bayes de Luna A, Cladellas M, Oter R, et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J 1988;9:1112-8.
25. Lorbar M, Levrault R, Phadke JG, Spodick DH. Interatrial block as a predictor of embolic stroke. Am J Cardiol 2005;95:667-668.
26. Chhabra L, Srinivasan I, Sareen P, Anand C, Spodick DH. Interatrial block - a novel risk factor for acute mesenteric ischemia. Indian J Gastroenterol 2012;31:191-194.
27. Cotter PE, Martin PJ, Pugh PJ, Warburton EA, Cheriyan J, Belham M. Increased incidence of interatrial block in younger adults with cryptogenic stroke and patent foramen ovale. Cerebrovasc Dis Extra 2011;1:36-43.
28. Başar N, Malçok Gürel O, Ozcan F, et al. Diagnostic accuracy of P-wave dispersion in prediction of maintenance of sinus rhythm after external cardioversion of atrial fibrillation. Anadolu Kardiyol Derg 2011;11:34-8.
29. Martín García A, Jiménez-Candil J, Hernández J, Martín García A, Martín Herrero F, Martín Luengo C. P wave morphology and recurrence after cardioversion of lone atrial fibrillation. Rev Esp Cardiol (Engl Ed) 2012;65:289-290.
30. Josephson ME, Kastor JA, Morganroth J. Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates. Am J Cardiol 1977;39:967-971.
31. Bayés de Luna A, Guindo J, Viñolas X, Martinez-Rubio A, Oter R, Bayés-Genís A. Third-degree inter-atrial block and supraventricular tachyarrhythmias. Europace 1999;1:43-6.